By Apeksha Damania
As AI-fueled innovations continue to transform medical technology and redefine therapeutic possibilities, organizations that anticipate the shift and prepare for the promise of precision medicine to come to fruition will be best set to join the next generation. In this two-part series, Guidehouse experts detail four key elements life sciences organizations must consider before drug therapies can take full advantage of precision medicine to meet the unique needs of patients.
Guidehouse is a global advisory, technology, and managed services firm delivering value to commercial businesses and federal, state, and local governments. Serving industries focused on communities, energy, infrastructure, healthcare, financial services, defense, and national security, Guidehouse positions clients for AI-led innovation, efficiency, and resilience.